Dolby Laboratories (DLB)
(Delayed Data from NYSE)
$79.58 USD
+0.42 (0.53%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $79.55 -0.03 (-0.04%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Cash flow Statements
Fiscal Year End for Dolby Laboratories falls in the month of September.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | 9/30/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 201.64 | 183.90 | 317.82 | 231.62 | 255.51 |
Depreciation/Amortization & Depletion | 94.65 | 105.05 | 114.13 | 91.68 | 85.48 |
Net Change from Assets/Liabilities | -42.00 | -56.25 | -24.64 | -81.05 | -94.43 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 112.78 | 85.88 | 40.44 | 101.60 | 81.12 |
Net Cash From Operating Activities | 367.08 | 318.58 | 447.75 | 343.85 | 327.67 |
Property & Equipment | -30.34 | -47.93 | -38.09 | -66.35 | -96.28 |
Acquisition/ Disposition of Subsidiaries | 25.70 | -38.17 | -4.50 | 0.00 | -14.92 |
Investments | 58.84 | -198.31 | -2.32 | 203.36 | 72.23 |
Other Investing Activities | 0.00 | -11.53 | 0.00 | -2.64 | -17.26 |
Net Cash from Investing Activities | 54.21 | -295.94 | -44.91 | 134.37 | -56.23 |
Uses of Funds
9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | 9/30/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -101.50 | -472.64 | -123.78 | -91.08 | -283.24 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -103.41 | -100.07 | -89.17 | -88.58 | -77.50 |
Other Financing Activities | -31.91 | -37.85 | -39.57 | -28.11 | -24.55 |
Net Cash from Financing Activities | -236.81 | -610.56 | -252.52 | -207.78 | -385.28 |
Effect of Exchange Rate Changes | 5.12 | -16.74 | 2.72 | 3.94 | -5.82 |
Net Change In Cash & Equivalents | 189.60 | -604.66 | 153.05 | 274.39 | -119.66 |
Cash at Beginning of Period | 628.37 | 1,233.03 | 1,079.98 | 805.59 | 925.25 |
Cash at End of Period | 817.97 | 628.37 | 1,233.03 | 1,079.98 | 805.59 |
Diluted Net EPS | 2.05 | 1.81 | 2.97 | 2.25 | 2.44 |
Fiscal Year End for Dolby Laboratories falls in the month of September.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | 67.58 | 201.64 | 191.74 | 175.33 |
Depreciation/Amortization & Depletion | NA | 20.07 | 94.65 | 71.08 | 46.99 |
Net Change from Assets/Liabilities | NA | -101.89 | -42.00 | -47.29 | -96.42 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 22.65 | 112.78 | 66.54 | 35.03 |
Net Cash From Operating Activities | NA | 8.41 | 367.08 | 282.07 | 160.94 |
Property & Equipment | NA | -6.10 | -30.34 | -22.15 | -14.74 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 25.70 | 25.70 | 0.00 |
Investments | NA | 6.73 | 58.84 | 70.37 | 66.63 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 0.63 | 54.21 | 73.92 | 51.89 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | -61.70 | -101.50 | -87.05 | -77.88 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | -28.55 | -103.41 | -77.58 | -51.74 |
Other Financing Activities | NA | -34.89 | -31.91 | -29.39 | -27.57 |
Net Cash from Financing Activities | NA | -125.14 | -236.81 | -194.01 | -157.19 |
Effect of Exchange Rate Changes | NA | 6.79 | 5.12 | 8.82 | 9.42 |
Net Change In Cash & Equivalents | NA | -109.31 | 189.60 | 170.79 | 65.05 |
Cash at Beginning of Period | NA | 817.97 | 628.37 | 628.37 | 628.37 |
Cash at End of Period | NA | 708.66 | 817.97 | 799.16 | 693.42 |
Diluted Net EPS | NA | 0.69 | 0.08 | 0.17 | 0.98 |